FDA Approves Adempas (Riociguat) for Pulmonary Hypertension

Home › FDA Approves Adempas (Riociguat) for Pulmonary Hypertension

The FDA has approved Adempas tablets for use in two forms of pulmonary hypertension.

12.11	Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11	Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11	Protech Group Acquires Caldwell Chemical Coatings
11.11	Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11	Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »

je.st